Colorectal Cancer Clinical Trials in Albuquerque, NM

Colorectal Cancer Clinical Trials in Albuquerque, NM

View the best 10 colorectal cancer medical studies in Albuquerque, New Mexico. Access promising new therapies by applying to a Albuquerque-based Colorectal Cancer clinical trial.

Top rated colorectal cancer clinical trials in Albuquerque, New Mexico

Here are the top 7 medical studies for colorectal cancer in Albuquerque, New Mexico

Image of Mayo Clinic Arizona in Phoenix, United States.

Tucatinib +5 More

Small Molecule Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial will study whether tucatinib is safe when given with other anti-cancer drugs to treat gastrointestinal cancer.
Image of Research Site in Los Angeles, United States.

Datopotamab deruxtecan (Dato-DXd)

Antibody-Drug Conjugate

Recruiting1 awardPhase 2
This trial will investigate the safety and effectiveness of a new cancer drug, given alone or with other cancer drugs.
Image of University of California Davis Comprehensive Cancer Center in Sacramento, United States.

Chemotherapy

Recruiting2 awardsPhase 3
This trial compares using intense local treatment to the usual approach of using only intravenous and/or oral medications to treat colorectal cancer spread to up to 4 sites.
Image of University of New Mexico - Cancer Center in Albuquerque, United States.

Breast, Colorectal, and Cervical Cancer Screening Interventions

Behavioral Intervention

Recruiting1 award5 criteria
This trial is testing ways to improve cancer screening for breast, colorectal, and cervical cancers in American Indians, who are less likely to follow recommended guidelines.
Image of University of South Alabama Mitchell Cancer Institute in Mobile, United States.

Quality-of-Life Assessment

Recruiting0 awardsPhase 2 & 3
This trial is testing duloxetine to see if it can help prevent pain, tingling, and numbness caused by oxaliplatin in patients with colorectal cancer.
Image of Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro in Jonesboro, United States.

Fluorouracil +4 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing a combination of chemotherapy drugs, bevacizumab, and atezolizumab to treat patients with metastatic colorectal cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Capivasertib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.

Popular filter options for colorectal-cancer albuquerque trials

Phase 3 Clinical Trials

View 14 phase 3 medical studies.

Clinical Trials With No Placebo

View 14 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.